Effect of Cholecalciferol on 24-hr ABPM and Vasoactive Hormones in Patients With Hypertension.

Trial Profile

Effect of Cholecalciferol on 24-hr ABPM and Vasoactive Hormones in Patients With Hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2012

At a glance

  • Drugs Colecalciferol (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 28 Aug 2012 New trial record
    • 02 Aug 2012 Primary endpoint 24-hour (ambulatory) systolic blood pressure has not been met according to results published in the American Journal of Hypertension.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top